Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Tiziana Life Sciences Ltd is a biotechnology business based in the US. Tiziana Life Sciences shares (TLSA) are listed on the NASDAQ and all prices are listed in US Dollars. Tiziana Life Sciences employs 14 staff and has a market cap (total outstanding shares value) of 0.00.
Our top pick for
Beginners
Our top pick for
Free trades
Our top pick for
Social traders
| Latest market close | $0.78 |
|---|---|
| 52-week range | $0.53 - $1.70 |
| 50-day moving average | $0.75 |
| 200-day moving average | $0.86 |
| Wall St. target price | $3.50 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.24 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.78 from 2022-09-23
| 1 week (2022-09-16) | 41.82% |
|---|---|
| 1 month (2022-08-26) | 4.00% |
| 3 months (2022-06-24) | -4.88% |
| 6 months (2022-03-25) | -32.76% |
| 1 year (2021-09-24) | -48.34% |
|---|---|
| 2 years (2020-09-25) | -77.65% |
| 3 years (2019-09-26) | 5.3563 |
| 5 years (2017-09-22) | N/A |
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -28.64% |
| Return on equity TTM | -45.18% |
| Profit margin | 0% |
| Book value | $0.40 |
| Market capitalisation | $70.2 million |
TTM: trailing 12 months
We're not expecting Tiziana Life Sciences to pay a dividend over the next 12 months.
Tiziana Life Sciences's shares were split on a 2499:1000 basis on 30 July 2020. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 2499 shares. This wouldn't directly have changed the overall worth of your Tiziana Life Sciences shares – just the quantity. However, indirectly, the new 60% lower share price could have impacted the market appetite for Tiziana Life Sciences shares which in turn could have impacted Tiziana Life Sciences's share price.
Over the last 12 months, Tiziana Life Sciences's shares have ranged in value from as little as $0.53 up to $1.7. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Tiziana Life Sciences's is -0.0158. This would suggest that Tiziana Life Sciences's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Tiziana Life Sciences has bucked the trend.
Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It also develops Milciclib (TZLS-201), a small molecule inhibitor of various cyclin-dependent kinases, tropomycin receptor kinases, and Src family kinases controlling cell growth and malignant progression of cancer; and anti-Interleukin 6 receptor (IL6R) mAb (TZLS-501), a fully human monoclonal antibody for the treatment of IL6-induced inflammation and to treat COVID-19 patients. The company was incorporated in 1998 and is headquatered in London, the United Kingdom. .
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
A simple guide to buying stocks in your favorite European soccer team.
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
We’ve rounded up stats on some of the most popular wheat stocks, along with information on how these stocks compare and how to invest.